Table 1.
Baseline characteristics.
Characteristics | Thyrotoxicosis (n=28) | Control (n=10) | P value | |
Age (years), mean (SD) | 34.9 (10.9) | 34.1 (5.9) | .78a | |
Gender, n (%) |
|
|
|
|
|
Male | 10 (36) | 3 (30) | .53b |
|
Female | 18 (64) | 7 (70) | |
Body mass index (kg/m2), mean (SD) | 20.6 (4.7) | 20.7 (1.6) | .93a | |
Blood pressure (mmHg), mean (SD) |
|
|
|
|
|
Systolic blood pressure | 130.2 (14.3) | 124.6 (11.4) | .27a |
|
Diastolic blood pressure | 78.1 (10.6) | 70.6 (9.6) | .06a |
On-site resting heart rate (bpmc), mean (SD) | 101.6 (14.5) | 81.9 (14.8) | .001a | |
Hyperthyroid symptom scale, mean (SD) | 12.5 (10.0) | 0.5 (2.8) | <.001d | |
Thyroid function test |
|
|
|
|
|
Free thyroxine (ng/dL), mean (SD) | 3.08 (1.09) | 1.36 (0.12) | <.001a |
|
Thyroid stimulating hormone (mIU/L), median (IQRe) | 0.01 (0.00) | 1.33 (1.19) | <.001d |
Thyrotropin-binding inhibitory immunoglobulin (IU/L), median (IQR) | 4.2 (10.3) | — | — | |
Glucose (mg/dL), mean (SD) | 105.8 (18.6) | 96.6 (23.1) | .24a | |
Blood urea nitrogen (mg/dL), mean (SD) | 13.0 (2.9) | 11.7 (2.4) | .20a | |
Creatinine (mg/dL), mean (SD) | 0.50 (0.20) | 0.69 (0.19) | .01a | |
Total cholesterol (mg/dL), mean (SD) | 141.7 (22.1) | 180.2 (22.8) | <.001a | |
Total protein (g/dL), mean (SD) | 7.1 (0.5) | 7.2 (0.4) | .37a | |
Albumin (g/dL), mean (SD) | 4.3 (0.3) | 4.4 (0.3) | .17a | |
Total bilirubin (mg/dL), mean (SD) | 0.69 (0.30) | 0.65 (0.26) | .69a | |
Aspartate aminotransferase (mg/dL), mean (SD) | 26.4 (10.4) | 18.3 (3.1) | .001a | |
Alanine aminotransferase (mg/dL), mean (SD) | 33.1 (22.0) | 15.1 (7.9) | .02a | |
White blood count (no/mm3), mean (SD) | 5347.3 (1980.1) | 5857.0 (1397.6) | .46a | |
Hemoglobin (mg/dL), mean (SD) | 14.0 (1.44) | 13.6 (1.4) | .42a | |
Platelet (no/mm3), mean (SD) | 182,200 (118,600) | 276,600 (59,100) | .02a |
aDerived from Student t test.
bDerived from Fisher exact probability test.
cbpm: beats per minute.
dDerived from Mann Whitney U test.
eIQR: interquartile range.